Abstract:Vaccination is credited as a significant medical achievement contributing to the decline in morbidity and mortality of infectious diseases. Traditional vaccines composed of inactivated and live-attenuated whole pathogens confer the induction of potent and long-term immune responses; however, traditional vaccines pose a high risk of eliciting autoimmune and allergic responses as well as inflammations. New modern vaccines, such as subunit vaccines, employ minimum pathogenic components (such as carbohydrates, proteins, or peptides), overcome the drawbacks of traditional vaccines and stimulate effective immunity against infections. However, the low immunogenicity of subunit vaccines requires effective immune stimulants (adjuvants), which are an indispensable factor in vaccine development. Although there are several approved adjuvants in human vaccines, the challenges of matching and designing appropriate adjuvants for specific vaccines, along with managing the side effects and toxicity of existing adjuvants in humans, are driving the development of new adjuvants. Self-assembling peptides are a promising biomaterial rapidly emerging in the fields of biomedicine, vaccination and material science. Here, peptides self-assemble into ordered supramolecular structures, forming different building blocks in nanoparticle size, including fibrils, tapes, nanotubes, micelles, hydrogels or nanocages, with great biostability, biocompatibility, low toxicity and effectiveness at controlled release. Self-assembling peptides are effective immunostimulatory agents used in vaccine development to enhance and prolong immune responses. This review describes the predominant structures of self-assembling peptides and summarises their recent applications as vaccine adjuvants. Challenges and future perspectives on self-assembled peptides as vaccine adjuvants are also highlighted.

Progress and prospect of polysaccharides as adjuvants in vaccine development

Polysaccharides As Vaccine Adjuvants

Polysaccharides: Candidates of promising vaccine adjuvants.

Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants

The Adjuvant Effects on Vaccine and the Immunomodulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine

[Research progress of new vaccine adjuvants].

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action

Polysaccharide conjugate vaccine: A kind of vaccine with great development potential

Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect

Stimulation of immune systems by conjugated polymers and their potential as an alternative vaccine adjuvant.

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

Progress in Adjuvants

Adjuvant Activities of Saponins from Traditional Chinese Medicinal Herbs.

Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines

Basic Properties and Development Status of Aluminum Adjuvants Used for Vaccines

Applications of polymer-based nanoparticles in vaccine field

Study and Application of Polyphosphazene Immunoadjuvant

Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

Self-Assembling Peptides for Vaccine Adjuvant Discovery

Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities